From my perspective, yes, I think there is. I would defer to my clinician colleagues on looking at that.
I think there is opportunity in looking at antimicrobial-resistant trending across the country and also globally so that you can see what's happening in other areas and there is ability to have some predictability about what may come to our borders.
However, that's not exactly my area of expertise.